NYSE : ZBH

Zimmer Biomet Holdings, Inc. — News

$88.85 USD

$0.17 (0.19%)

Volume
601.12K
Average Volume
2.48M
Market Capitalization
$17.19B
P/E Ratio
22.96
Dividend Yield
1.08%
Price Target
$92.00
Year High
$108.29
Year Low
$79.12
Day High
Day Low
Payout Ratio
$0.25
Current Ratio
$1.73
Source Headline
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-07-21 10:41:07

D.A. Davidson & CO. Has $2.67 Million Stake in Zimmer Biomet Holdings, Inc. $ZBH

D.A. Davidson and CO. boosted its stake in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 170.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,520 shares of the medical equipment provider's stock after acquiring an additional 18,597 shares during the

defenseworld.net - 2026-07-21 04:18:56

Zimmer Biomet Names Chintan Desai President of Asia Pacific Region

WARSAW, Ind., July 14, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Chintan Desai has been named president of the company's Asia Pacific Region, effective immediately.

prnewswire.com - 2026-07-14 07:00:00

Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results

WARSAW, Ind., July 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its second quarter earnings conference call will be webcast on Wednesday, August 5, 2026 at 8:30 a.m.

prnewswire.com - 2026-07-13 07:30:00

Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?

Zimmer Biomet ZBH appears well positioned for growth in the coming quarters, supported by the continued execution of its market strategies centered on People and Culture, Operational Excellence, and Innovation and Diversification pillars. Growth in the knee business revenues is backed by the robust adoption of its cementless offerings.

zacks.com - 2026-07-10 15:11:15

Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-07-02 10:40:31

Medical device maker Zimmer Biomet to hire 500 in 3 years for tech centre in India

Medical device maker Zimmer Biomet plans to hire 500 employees over the next three years ​for its newly opened technology centre in Bengaluru, a senior ‌executive said, as the U.S.-listed company expands its presence in India.

reuters.com - 2026-07-02 05:37:38

Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal

PCRX is set to sell its iovera franchise to ZBH in a deal worth up to $140M as it sharpens focus on biopharmaceutical growth.

zacks.com - 2026-07-01 10:30:49

ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?

ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.

zacks.com - 2026-06-24 12:25:33

Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-18 10:51:05

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-16 10:40:48

Zimmer Biomet: Does Slow And Steady Still Win The Race?

Zimmer Biomet Holdings trades at a steep valuation discount despite strong free cash flow and high margins. ZBH's entrenched position in orthopedic implants, robust cash generation, and loyal installed base underpin reliable earnings. Recent results show net sales up 9.3%, adjusted EPS up 15.5%, and adjusted gross margin rising to 73.0%.

seekingalpha.com - 2026-06-16 03:52:09

Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-06-08 17:08:30

Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet

prnewswire.com - 2026-06-02 07:30:00

Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-05-28 12:36:15

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026

WARSAW, Ind., May 22, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2026.

prnewswire.com - 2026-05-22 16:30:00

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-05-18 10:40:23

ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?

Abbott vs. Zimmer Biomet: surgical equipment stocks face diverging growth, acquisitions, and valuation shifts as investors weigh momentum and margins.

zacks.com - 2026-05-18 10:16:18

Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-13 15:31:06

Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End

WARSAW, Ind., May 12, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.

prnewswire.com - 2026-05-12 06:30:00

Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference

/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet

prnewswire.com - 2026-05-06 07:30:00

Why Zimmer Biomet (ZBH) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-05-04 10:46:22

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-05-01 10:40:38

Cwm LLC Reduces Stock Position in Zimmer Biomet Holdings, Inc. $ZBH

Cwm LLC decreased its position in shares of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 60.8% during the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 9,377 shares of the medical equipment provider's stock after selling 14,532 shares during the period. Cwm LLC's holdings in Zimmer Biomet

defenseworld.net - 2026-04-29 15:50:50

These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported upbeat earnings for the first quarter on Tuesday.

benzinga.com - 2026-04-29 11:10:03

Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported first-quarter adjusted earnings of $2.09 per share, up 15.5% year over year, beating the Street estimates of $1.86.

benzinga.com - 2026-04-28 14:55:39

Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript

Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-28 14:11:44

Zimmer (ZBH) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com - 2026-04-28 10:32:14

ZBH Q1 Earnings & Revenues Top Estimates, Stock Dips in Pre-Market

Zimmer Biomet tops Q1 EPS and revenue estimates with strong segment growth and margin expansion, yet shares slip 1.8% premarket after results.

zacks.com - 2026-04-28 10:27:18

Zimmer Biomet (ZBH) Q1 Earnings and Revenues Top Estimates

Zimmer Biomet (ZBH) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $1.81 per share a year ago.

zacks.com - 2026-04-28 08:41:09

Medical device maker Zimmer Biomet raises annual profit forecast, announces CFO departure

Zimmer Biomet on Tuesday raised its 2026 adjusted profit forecast after reporting better-than-expected quarterly results, helped by ​strong demand for its medical devices and new product ‌launches.

reuters.com - 2026-04-28 08:29:23

Zimmer Biomet Announces First Quarter 2026 Financial Results

First quarter net sales of $2.087 billion increased 9.3% on a reported basis, 6.8% on a constant currency1 basis and 2.9% on an organic constant currency1 basis First quarter diluted earnings per share were $1.22, an increase of 34.1%; adjusted1 diluted earnings per share were $2.09, an increase of 15.5% Company updates full-year 2026 financial guidance WARSAW, Ind., April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2026.

prnewswire.com - 2026-04-28 06:30:00

Zimmer Biomet Announces Chief Financial Officer Transition

Suketu Upadhyay to Depart; Paul Stellato Named Interim CFO WARSAW, Ind., April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance, Operations and Supply Chain, will depart the company effective April 28 for a new professional opportunity.

prnewswire.com - 2026-04-28 06:29:00

Get ZBH Insider Trade Alerts

ZBH Price Target Summary

Last Month

$95.00

1 analysts

Last Quarter

$93.50

6 analysts

Last Year

$102.48

21 analysts

All Time

$122.80

66 analysts

ZBH Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-09 BMO Capital Downgrade Outperform Market Perform
2026-07-06 Evercore ISI Group Maintain Outperform Outperform
2026-05-28 Citigroup Maintain Neutral Neutral
2026-04-29 Stifel Maintain Buy Buy
2026-04-29 Barclays Maintain Underweight Underweight
2026-04-29 Citizens Maintain Market Outperform Market Outperform
2026-04-29 Citigroup Maintain Neutral Neutral
2026-04-29 Wells Fargo Maintain Equal Weight Equal Weight
2026-04-29 JP Morgan Maintain Neutral Neutral
2026-04-29 Truist Securities Maintain Hold Hold
2026-03-23 BTIG Downgrade Buy Neutral
2026-02-12 Barclays Maintain Underweight Underweight
2026-02-11 Wells Fargo Maintain Equal Weight Equal Weight
2026-02-11 Citigroup Maintain Neutral Neutral
2026-02-10 Needham Maintain Hold Hold
2026-02-10 BTIG Maintain Buy Buy
2026-01-28 UBS Maintain Sell Sell
2026-01-09 Bernstein Maintain Market Perform Market Perform
2026-01-08 BTIG Maintain Buy Buy
2026-01-05 Evercore ISI Group Upgrade In Line Outperform